Don't ignore those symptoms. Head and neck cancers are far more manageable, and often curable, with less aggressive treatment ...

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

Cancer is a debilitating illness that remains a persistent threat to humanity and is one of the leading causes of death ...

The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...

DelveInsight’s Head and Neck Cancer pipeline report depicts a robust space with 80+ active players working to develop 100+ ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

Exciting developments in cancer treatment were unveiled at the AACR meeting. Boehringer Ingelheim's zongertinib shows a 71% ...

Advanced-stage cancers often require a combination ... Take charge of your health Many symptoms of head and neck cancer can be mistaken for less serious conditions like allergies or throat ...